Mr. Bryan Baldasare - 16 Dec 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Bryan Baldasare
Issuer symbol
INM
Transactions as of
16 Dec 2022
Net transactions value
$0
Form type
4
Filing time
19 Dec 2022, 15:50:47 UTC
Previous filing
19 May 2022
Next filing
26 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +840 +150% $0.000000 1,400 16 Dec 2022 Common shares 840 $1.78 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 12/16/2022 and will vest as follows: Vesting 100% on the one-year anniversary of the grant date (Dec 16, 2023) or immediately prior to the next AGM, whichever is sooner.
F2 On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split.